These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7705363)

  • 1. Monoclonal antibodies as site-specific probes for the acetylcholine-receptor delta-subunit tyrosine and serine phosphorylation sites.
    Tzartos SJ; Kouvatsou R; Tzartos E
    Eur J Biochem; 1995 Mar; 228(2):463-72. PubMed ID: 7705363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies against the acetylcholine receptor gamma-subunit as site specific probes for receptor tyrosine phosphorylation.
    Tzartos SJ; Tzartos E; Tzartos JS
    FEBS Lett; 1995 Apr; 363(1-2):195-8. PubMed ID: 7537227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tyrosine phosphorylation site of the acetylcholine receptor beta subunit is located in a highly immunogenic epitope implicated in channel function: antibody probes for beta subunit phosphorylation and function.
    Tzartos SJ; Valcana C; Kouvatsou R; Kokla A
    EMBO J; 1993 Dec; 12(13):5141-9. PubMed ID: 7505221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epitope mapping of monoclonal antibodies to Torpedo acetylcholine receptor gamma subunits, which specifically recognize the epsilon subunit of mammalian muscle acetylcholine receptor.
    Nelson S; Shelton GD; Lei S; Lindstrom JM; Conti-Tronconi BM
    J Neuroimmunol; 1992 Jan; 36(1):13-27. PubMed ID: 1370956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a cytoplasmic region of the Torpedo nicotinic acetylcholine receptor alpha-subunit by epitope mapping.
    Pedersen SE; Bridgman PC; Sharp SD; Cohen JB
    J Biol Chem; 1990 Jan; 265(1):569-81. PubMed ID: 1688436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of monoclonal antibodies against the carboxyl terminal segment of the nicotinic receptor delta subunit suggests an unusual transmembrane disposition of this sequence region.
    Lei S; Okita DK; Conti-Fine BM
    Biochemistry; 1995 May; 34(20):6675-88. PubMed ID: 7756299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precise epitope mapping of monoclonal antibodies to the cytoplasmic side of the acetylcholine receptor alpha subunit. Dissecting a potentially myasthenogenic epitope.
    Tzartos SJ; Remoundos MS
    Eur J Biochem; 1992 Aug; 207(3):915-22. PubMed ID: 1379917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping of a cholinergic binding site by means of synthetic peptides, monoclonal antibodies, and alpha-bungarotoxin.
    Conti-Tronconi BM; Tang F; Diethelm BM; Spencer SR; Reinhardt-Maelicke S; Maelicke A
    Biochemistry; 1990 Jul; 29(26):6221-30. PubMed ID: 2207067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Main immunogenic region of Torpedo electroplax and human muscle acetylcholine receptor: localization and microheterogeneity revealed by the use of synthetic peptides.
    Tzartos SJ; Loutrari HV; Tang F; Kokla A; Walgrave SL; Milius RP; Conti-Tronconi BM
    J Neurochem; 1990 Jan; 54(1):51-61. PubMed ID: 1688377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of epitopes within a highly immunogenic region of acetylcholine receptor by a phage epitope library.
    Barchan D; Balass M; Souroujon MC; Katchalski-Katzir E; Fuchs S
    J Immunol; 1995 Nov; 155(9):4264-9. PubMed ID: 7594584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solution conformation of the antibody-bound tyrosine phosphorylation site of the nicotinic acetylcholine receptor beta-subunit in its phosphorylated and nonphosphorylated states.
    Phan-Chan-Du A; Hemmerlin C; Krikorian D; Sakarellos-Daitsiotis M; Tsikaris V; Sakarellos C; Marinou M; Thureau A; Cung MT; Tzartos SJ
    Biochemistry; 2003 Jun; 42(24):7371-80. PubMed ID: 12809492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of human-Torpedo hybrid acetylcholine receptor (AChR) for analysing the subunit specificity of antibodies in sera from patients with myasthenia gravis (MG).
    Loutrari H; Kokla A; Trakas N; Tzartos SJ
    Clin Exp Immunol; 1997 Sep; 109(3):538-46. PubMed ID: 9328134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epitope mapping of antibodies to acetylcholine receptor alpha subunits using peptides synthesized on polypropylene pegs.
    Das MK; Lindstrom J
    Biochemistry; 1991 Mar; 30(9):2470-7. PubMed ID: 1705819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of monoclonal antibodies to denatured Torpedo and to native calf acetylcholine receptors: species, subunit and region specificity.
    Tzartos S; Langeberg L; Hochschwender S; Swanson LW; Lindstrom J
    J Neuroimmunol; 1986 Jan; 10(3):235-53. PubMed ID: 3484485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-resolution epitope mapping and fine antigenic characterization of the main immunogenic region of the acetylcholine receptor. Improving the binding activity of synthetic analogues of the region.
    Papadouli I; Sakarellos C; Tzartos SJ
    Eur J Biochem; 1993 Jan; 211(1-2):227-34. PubMed ID: 7678806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural characterization of the main immunogenic region of the Torpedo acetylcholine receptor.
    Morell SW; Trinh VB; Gudipati E; Friend A; Page NA; Agius MA; Richman DP; Fairclough RH
    Mol Immunol; 2014 Mar; 58(1):116-31. PubMed ID: 24333757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Torpedo-mouse hybrid acetylcholine receptors reveals immunodominance of the alpha subunit in myasthenia gravis antisera.
    Loutrari H; Tzartos SJ; Claudio T
    Eur J Immunol; 1992 Nov; 22(11):2949-56. PubMed ID: 1385157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies to cytoplasmic domains of the acetylcholine receptor.
    Froehner SC; Douville K; Klink S; Culp WJ
    J Biol Chem; 1983 Jun; 258(11):7112-20. PubMed ID: 6189834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope.
    Atassi MZ; Oshima M; Deitiker P
    Crit Rev Immunol; 2001; 21(1-3):1-27. PubMed ID: 11642597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequence analysis of anti-AChR antibodies in experimental autoimmune myasthenia gravis.
    Graus Y; Meng F; Vincent A; van Breda Vriesman P; de Baets M
    J Immunol; 1995 Jun; 154(12):6382-96. PubMed ID: 7539019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.